Insider Buying Forte Biosciences, Inc. Insider Buys 25,000 Shares of Stock
| FBRX Stock | USD 18.96 4.19 18.10% |
Slightly above 56% of all Forte Biosciences' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Forte Biosciences suggests that some traders are interested. Forte Biosciences' investing sentiment can be driven by a variety of factors including economic data, Forte Biosciences' earnings reports, geopolitical events, and overall market trends.
Forte |
Forte Biosciences, Inc. insider Paul A. Wagner acquired 25,000 shares of Forte Biosciences stock in a transaction that occurred on Monday, December 11th. The stock was bought at an average price of 0.65 per share, with a total value of 16,250.00. Following the purchase, the insider now directly owns 1,787,940
Read at thelincolnianonline.com
 |
Forte Biosciences Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Forte Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Forte Biosciences Fundamental Analysis
We analyze Forte Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Forte Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Forte Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Forte Biosciences is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Forte Biosciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Forte Biosciences stock to make a market-neutral strategy. Peer analysis of Forte Biosciences could also be used in its relative valuation, which is a method of valuing Forte Biosciences by comparing valuation metrics with similar companies.
Peers
Forte Biosciences Related Equities
| EWTX | Edgewise Therapeutics | 18.36 | ||||
| HOWL | Werewolf Therapeutics | 0.61 | ||||
| CELC | Celcuity LLC | 0.24 | ||||
| CCCC | C4 Therapeutics | 1.60 | ||||
| KTTA | Pasithea Therapeutics | 1.89 | ||||
| ABVC | ABVC Biopharma | 1.92 | ||||
| RZLT | Rezolute | 2.18 | ||||
| ERAS | Erasca | 2.66 | ||||
| TPST | Tempest Therapeutics | 3.61 | ||||
| INDP | Indaptus Therapeutics | 4.00 |
Additional Tools for Forte Stock Analysis
When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.